News

May 5, 2022; Omaha, NE — Meridian Clinical Research, a leading multi-specialty investigative research site network, has promoted several employees to its leadership team and hired Marty Anderson as Chief Strategy Officer, and Michelle Rule as Senior Vice President, Strategic Operations. The following members of Meridian’s leadership team have been promoted: Laura Falcone, APRN, is President Kathy Stoddard RN, CCRC, is Chief Operating Officer Andrew Kimball is Chief Commercial Officer Stephanie Anderson is Chief People Officer Beau Garland is Chief Technology Officer Wes Bonner is Chief Relationship Officer … Read more

Meridian Clinical Research, a leading multi-specialty investigative research site network, has partnered with Raleigh Neurology Associates, PA, a premier provider of neurological care that has served the Triangle area for almost 40 years. The research site will be located within the Raleigh Neurology clinic at 1520 Sunday Drive, Suite 301, Raleigh, NC 27607. Raleigh Neurology’s distinguished physicians — including Kenneth Carnes, MD, PhD, A. Thomas Perkins IV, MD, PhD, Bradley Robottom, MD, and John Scagnelli, MD — will serve as principal investigators, overseeing clinical trials for investigational products … Read more

Meridian Clinical Research, a leading multi-specialty investigative research site network, has partnered with Kansas City Allergy & Asthma (KCAA), a premier provider of allergy and asthma care that has served the region for more than 40 years. The research site will be located within KCAA’s Overland Park clinic at 8675 College Blvd, Suite 200, Overland Park, KS 66210. The following physicians will serve as principal investigators to oversee clinical trials for investigational products intended to help treat allergies, asthma, and related conditions. Mark R. Neustrom, DO Derrick R. … Read more

Meridian enrolled the first participant in Moderna’s Phase 1 clinical trial for an Epstein-Barr virus (EBV) vaccine candidate (mRNA-1189). Congratulations to Moderna, and to Brandon Essink, MD, CPI, and our team in Omaha, Nebraska! Read the Moderna press release >

Meridian Clinical Research, a leading multi-specialty investigative research site network, won the first ever Excellence in Patient Centricity Award from the Society for Clinical Research Sites (SCRS). The award was presented to Meridian at the 2021 Global Site Solutions Summit in Hollywood, FL. Sponsored by Sanofi, the award was created to, “Celebrate a clinical research site that has proven its commitment to effective patient engagement by understanding clinical research from the patient perspective. Through the consideration of patient insights, the recipient of this award works tirelessly to produce … Read more

Meridian Clinical Research, a leading multi-specialty investigative research network, has opened a new site in Charleston, SC. Meridian is partnering with Neighbors Pediatrics, an organization providing quality medical care to children of all ages. The research site is located at 1871 Savage Rd., Charleston, SC 29407. Todd R. Vasko, MD, Philip J. McGaha, MD, and John “Jay” A. Traynham, MD, will serve as principal investigators to conduct clinical trials related to pediatrics, including vaccine studies. Each is board certified in pediatrics and have been practicing medicine for over … Read more

Inc. magazine ranked Meridian Clinical Research as 1,145 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Headquartered in Omaha, NE, Meridian is a multi-specialty site network with 29 sites nationwide. The company’s ranking reflects growth from 2017 to 2020. Since 2020, Meridian has enrolled more than 8,000 patients into COVID-19 vaccine studies and has expanded its operations. In July, Meridian announced its acquisition of Sterling Research Group in Cincinnati, OH. Each year, Meridian donates to charities and causes that operate … Read more

Meridian Clinical Research, a leading multi-specialty investigative research network, has opened a new site in Portsmouth, VA. Meridian is partnering with Churchland Family Medicine, an organization providing medical care to all ages since 1987. The research site is located at 3235 Academy Ave., Suite 101, Portsmouth, VA, 23703. Frederick C. Crum, MD and Banu Myneni, DO will serve as principal investigators to conduct clinical trials related to general medicine and infectious diseases, including vaccine studies for people of all ages. Dr. Crum specializes in geriatric medicine and has … Read more

Meridian Clinical Research, a leading multi-specialty investigative research network, has acquired the assets and operations of Sterling Research Group. The acquisition includes Sterling’s three sites in Cincinnati, and expands Meridian’s footprint to 27 sites nationwide. Effective immediately, Meridian will operate Sterling’s sites at the following three locations: Auburn: 2230 Auburn Avenue, Level B, Cincinnati, OH 45219 Springdale: 375 Glensprings Drive, 2nd Floor, Cincinnati, OH 45246 Downtown (MidWest Eye Center): 2055 Reading Rd., Suite 330, Cincinnati, OH 45202 “Meridian and Sterling collaborated closely for decades,” said Nicole Osborn, Founder … Read more

Meridian Clinical Research, a leading multi-specialty site network, has hired Michael Pierre as Senior Director of Systems Management. At Meridian, Michael will manage the implementation of the company’s clinical trial management system (CTMS), as well as its eSource, eRegulatory, and eConsent technologies. He will help develop and uphold system practices and quality standards that align with Meridian’s policies. Pierre brings more than 20 years of clinical research experience to his role at Meridian. He was previously the Director of Special Projects for the Society for Clinical Research Sites … Read more